Onderneming Sunshine Biopharma, Inc. Other OTC
Aandelen
US8677811064
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 24 | 100,0 % | +454,42% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 24 | 100,0 % | +454,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 15-10-09 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 15-10-09 |
Marc Beaudoin
COO | Chief Operating Officer | - | 25/01 |
Chief Tech/Sci/R&D Officer | 60 | 01-02-16 | |
Malek Chamoun
PRN | Corporate Officer/Principal | 39 | 25/01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 01-02-22 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 15-10-09 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 15-10-09 |
Chief Tech/Sci/R&D Officer | 60 | 01-02-16 | |
Rabi Kiderchah
BRD | Director/Board Member | 51 | 31-10-21 |
Andrew Keller
BRD | Director/Board Member | 70 | 10-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 994 529 | 900 534 ( 90,55 %) | 0 | 90,55 % |
Aandeel B | 0 | 10 000 | 0 | 0 |
Bedrijfsgegevens
Sunshine Biopharma, Inc.
1177 Avenue of the Americas 5th Floor
10036, New York
+
http://www.sunshinebiopharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,67% | 695 mld. | |
+26,51% | 568 mld. | |
-4,63% | 361 mld. | |
+19,59% | 330 mld. | |
+3,58% | 283 mld. | |
+16,79% | 239 mld. | |
+8,73% | 204 mld. | |
-7,81% | 198 mld. | |
+8,76% | 168 mld. |